MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds-Convertible12Promissory Notes
$1,800K
Proceeds from capital
contributions
$1,745K
Proceeds-Convertible Bridge Loans
$90K
Proceeds from conversion
of warrants to...
$11K
Net cash provided by
financing activities
$2,646K
Canceled cashflow
$1,000K
Net (decrease)
increase in cash, cash...
-$206K
Canceled cashflow
$2,646K
Net income (loss)
$15,350K
Accounts payable and
accrued expenses
$1,079K
Loss on issuance of
financial instruments...
-$1,050K
Stock-based compensation
$707K
Noncash interest
expense (including...
$403K
Depreciation and
amortization
$341K
Amortization of right-of-use
asset
$38K
Payment of revolving
line of credit
$1,000K
Net cash used in
operating activities
-$2,800K
Canceled cashflow
$18,968K
Net cash (used in)
provided by investing...
-$52K
Change in fair value of
financial instruments...
$21,575K
Prepaid expenses and
other current assets
$128K
Operating lease liability
-$40K
Other current
liabilities
-$25K
Purchases of capitalized
software
$52K
Back
Back
Cash Flow
source: myfinsight.com
NKGen Biotech, Inc. (NKGN)
NKGen Biotech, Inc. (NKGN)